Bonnefoy Luc 4
4 · Bausch & Lomb Corp · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Bonnefoy Luc
President, Surgical
Transactions
- Award
Non-Qualified Stock Options (right to purchase)
2024-02-28+50,813→ 50,813 totalExercise: $16.85→ Common Shares, No Par Value (50,813 underlying) - Award
Common Shares, No Par Value
2024-02-28+16,778→ 59,267 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.
- [F2]Reflects the grant of stock options to purchase common shares under the Plan.
- [F3]The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.
- [F4]The stock options will expire on the tenth anniversary of the grant date.